两项随机对照试验中ARDS亚型随时间稳定性的分析
该研究对ARMA和ALVEOLI两项ARDS随机对照试验的数据进行二次分析,采用潜在类别分析与潜在转变分析评估第0天和第3天的ARDS亚型稳定性。结果显示多数患者(>94%)在两次评估中保持同一亚型,但第2类亚型在第3天出现进行性器官衰竭迹象,且第3天亚型分类与临床结局关联更强。
要点
- ARDS亚型在入组后前3天基本稳定,>94%患者保持同一亚型。
- 第2类亚型患者第3天出现进行性器官衰竭,临床结局更差。
- 第3天亚型分类与临床结局关联强度高于第0天。
核心结论
- 在两项ARDS Network试验中,ARDS亚型在入组后前3天基本稳定,提示在临床试验背景下进行亚型识别具有可行性。
研究设计与样本
- 对ARMA试验(肺保护性通气,n=473,仅随机至低潮气量组)和ALVEOLI试验(低与高呼气末正压,n=549)进行二次分析,应用潜在类别分析和潜在转变分析,独立于临床结局。
主要发现
- 在ALVEOLI试验中,潜在类别分析在第0天和第3天均强烈支持两个ARDS潜在类别;在ARMA试验中,第0天支持两个类别的证据强于第3天。
- 两个类别的临床和生物学特征与既往工作相似且随时间大体稳定,但第2类在第3天表现出进行性器官衰竭的迹象,而第1类无此表现。
- 在潜在类别分析和潜在转变分析模型中,多数患者(>94%)从第0天至第3天保持在同一类别。
- 第2类的临床结局在统计学上显著差于第1类,且与第3天类别分配的关联更强。
临床怎么用
- ARDS亚型在入组前3天基本稳定,支持在临床试验中基于早期数据识别亚型并进行分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Two distinct acute respiratory distress syndrome (ARDS) subphenotypes have been identified using data obtained at time of enrolment in clinical trials; it remains unknown if these subphenotypes are durable over time. OBJECTIVE: To determine the stability of ARDS subphenotypes over time. METHODS: Secondary analysis of data from two randomised controlled trials in ARDS, the ARMA trial of lung protective ventilation (n=473; patients randomised to low tidal volumes only) and the ALVEOLI trial of low versus high positive end-expiratory pressure (n=549). Latent class analysis (LCA) and latent transition analysis (LTA) were applied to data from day 0 and day 3, independent of clinical outcomes. MEASUREMENTS AND MAIN RESULTS: In ALVEOLI, LCA indicated strong evidence of two ARDS latent classes at days 0 and 3; in ARMA, evidence of two classes was stronger at day 0 than at day 3. The clinical and biological features of these two classes were similar to those in our prior work and were largely stable over time, though class 2 demonstrated evidence of progressive organ failures by day 3, compared with class 1. In both LCA and LTA models, the majority of patients (>94%) stayed in the same class from day 0 to day 3. Clinical outcomes were statistically significantly worse in class 2 than class 1 and were more strongly associated with day 3 class assignment. CONCLUSIONS: ARDS subphenotypes are largely stable over the first 3 days of enrolment in two ARDS Network trials, suggesting that subphenotype identification may be feasible in the context of clinical trials.
引用
- Delucchi K, Famous KR, Ware LB, et al. Stability of ARDS subphenotypes over time in two randomised controlled trials. Thorax. 2018. PMID: 29477989. doi:10.1136/thoraxjnl-2017-211090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。